BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20631151)

  • 1. Advances in human B19 erythrovirus biology.
    Servant-Delmas A; Lefrère JJ; Morinet F; Pillet S
    J Virol; 2010 Oct; 84(19):9658-65. PubMed ID: 20631151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypes of erythrovirus B19, their geographical distribution & circulation in cases with various clinical manifestations.
    Jain A; Kant R
    Indian J Med Res; 2018 Mar; 147(3):239-247. PubMed ID: 29923512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of the human parvovirus B19 biology.
    Servant-Delmas A; Morinet F
    Transfus Clin Biol; 2016 Feb; 23(1):5-12. PubMed ID: 26778837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
    Zou W; Wang Z; Xiong M; Chen AY; Xu P; Ganaie SS; Badawi Y; Kleiboeker S; Nishimune H; Ye SQ; Qiu J
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Replication and Infection of Human Parvovirus B19.
    Ganaie SS; Qiu J
    Front Cell Infect Microbiol; 2018; 8():166. PubMed ID: 29922597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current molecular epidemiology and human parvovirus B19 infection.
    Umene K; Nunoue T
    Pathol Biol (Paris); 2002 Jun; 50(5):285-94. PubMed ID: 12116847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human parvovirus B19: a review.
    Rogo LD; Mokhtari-Azad T; Kabir MH; Rezaei F
    Acta Virol; 2014; 58(3):199-213. PubMed ID: 25283854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrovirus B19 infection in humans.
    Kishore J; Kapoor A
    Indian J Med Res; 2000 Nov; 112():149-64. PubMed ID: 12452123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process.
    Adamson-Small LA; Ignatovich IV; Laemmerhirt MG; Hobbs JA
    Virus Res; 2014 Sep; 190():8-16. PubMed ID: 24998884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human parvovirus B19: a review of clinical and epidemiological aspects in Brazil.
    Cnc Garcia R; Leon LA
    Future Microbiol; 2021 Jan; 16(1):37-50. PubMed ID: 33438475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19.
    Corcoran A; Doyle S
    J Med Microbiol; 2004 Jun; 53(Pt 6):459-475. PubMed ID: 15150324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia.
    Regaya F; Oussaief L; Bejaoui M; Karoui M; Zili M; Khelifa R
    BMC Infect Dis; 2007 Oct; 7():123. PubMed ID: 17961236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular-genetic characterization of human parvovirus B19 prevalent in Kerala State, India.
    Seetha D; Pillai HR; Nori SRC; Kalpathodi SG; Thulasi VP; Nair RR
    Virol J; 2021 May; 18(1):96. PubMed ID: 33952289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel B19-like parvovirus in the brain of a harbor seal.
    Bodewes R; Rubio García A; Wiersma LC; Getu S; Beukers M; Schapendonk CM; van Run PR; van de Bildt MW; Poen MJ; Osinga N; Sánchez Contreras GJ; Kuiken T; Smits SL; Osterhaus AD
    PLoS One; 2013; 8(11):e79259. PubMed ID: 24223918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.
    Thammasri K; Rauhamäki S; Wang L; Filippou A; Kivovich V; Marjomäki V; Naides SJ; Gilbert L
    PLoS One; 2013; 8(6):e67179. PubMed ID: 23776709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a second novel human erythrovirus variant, A6.
    Nguyen QT; Wong S; Heegaard ED; Brown KE
    Virology; 2002 Sep; 301(2):374-80. PubMed ID: 12359439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates.
    Schalasta G; Schmid M; Lachmund T; Enders G
    J Med Virol; 2004 May; 73(1):54-9. PubMed ID: 15042648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvovirus B19 is a bystander in adult myocarditis.
    Koepsell SA; Anderson DR; Radio SJ
    Cardiovasc Pathol; 2012; 21(6):476-81. PubMed ID: 22425629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical use of parvovirus B19 assays: recent advances.
    Gallinella G
    Expert Rev Mol Diagn; 2018 Sep; 18(9):821-832. PubMed ID: 30028234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular epidemiology of parvovirus infection in Belarus].
    Ermoloich MA; Semeĭko GV; Samoĭlovich EO; Hubschen JM; Muller CP
    Vopr Virusol; 2010; 55(2):26-31. PubMed ID: 20455468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.